Neurological Features During COVID19

Centre d'Investigation Clinique et Technologique 80530 enrolled

Overview

Description of the neurological impairment: clinico-radiological and electrophysilogical correlations

Describe short and long term clinical radiological and electrophysilogical presentations of neurological damage central and peripheral SARS COV2 infection Describe the association between neurological, respiratory and dysautonomic Determine the prognosis of neurological damages to short and long term.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Encephalitis

Interventions

ObservationOTHER

Observation of recorded neurological signs

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * PCR SARS COV2 positive or CT Scan * Central neurological signs such as confusion, epilepsy, abnormal movement, pyramidal signs, motor or sensory deficit, involvement of cranial pairs (such as anomie or ageusia) or peripheral. * Dysautonomic signs such as hypotension or hypertension, bradycardia or tachycardia, hypothermia, SIADH not explained by therapy or a pathology other than SARS COV 2 infection Exclusion Criteria: * Contraindication to performing an MRI scan * Minor * Pregnant woman * No follow-up possible at 6 months

Locations (1)

Hopital Raymond Poincare

Garches, France

RECRUITING

Outcomes

Primary Outcomes

Primary

incidence of objective neurological damage

Time frame: 6 months

Secondary Outcomes

Secondary

incidence of clinical neurological damage incidence of radiological neurological damage incidence of neurophysiological neurological damage

Time frame: 6 months

Central Contacts

David Orlikowski, MD PhD

CONTACT

0147107777 david.orlikowski@aphp.fr

Isabelle Bossard

CONTACT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.